Holen Sie sich die Stockscreener-App
14.99
2.25%
0.33
Handel nachbörslich:
14.99
Schlusskurs vom Vortag:
$14.66
Offen:
$14.72
24-Stunden-Volumen:
1.73M
Relative Volume:
1.25
Marktkapitalisierung:
$1.46B
Einnahmen:
$221.08M
Nettoeinkommen (Verlust:
$-2.92M
KGV:
299.80
EPS:
0.05
Netto-Cashflow:
$5.89M
1W Leistung:
+2.53%
1M Leistung:
+33.13%
6M Leistung:
+96.20%
1J Leistung:
+1.83%
1-Tages-Spanne:
$14.54
$15.13
1-Wochen-Bereich:
$14.21
$15.41
52-Wochen-Spanne:
$6.38
$16.66
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Firmenname
Avadel Pharmaceuticals Plc
Sektor
Telefon
636-449-1830
Adresse
BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN
Vergleichen Sie AVDL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
14.99 | 1.45B | 221.08M | -2.92M | 5.89M | 0.05 |
|
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2024-06-12 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-03-05 | Bestätigt | H.C. Wainwright | Buy |
| 2024-03-05 | Bestätigt | Needham | Buy |
| 2024-03-05 | Bestätigt | Oppenheimer | Outperform |
| 2024-02-06 | Eingeleitet | UBS | Buy |
| 2022-11-30 | Hochstufung | Jefferies | Hold → Buy |
| 2022-08-10 | Herabstufung | Jefferies | Buy → Hold |
| 2022-07-28 | Fortgesetzt | Craig Hallum | Buy |
| 2022-05-26 | Herabstufung | Stifel | Buy → Hold |
| 2021-09-23 | Eingeleitet | Needham | Buy |
| 2020-07-31 | Eingeleitet | Oppenheimer | Outperform |
| 2020-07-21 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-03 | Eingeleitet | Jefferies | Buy |
| 2020-03-12 | Eingeleitet | Stifel | Buy |
| 2020-02-26 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-30 | Eingeleitet | Craig Hallum | Buy |
| 2019-06-14 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2019-02-08 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
Alle ansehen
Avadel Pharmaceuticals Plc Aktie (AVDL) Neueste Nachrichten
Avadel licenses once-at-bedtime oxybate therapy from XWPharma - Investing.com
Avadel Pharmaceuticals and XWPharma Enter Exclusive License Agreement for Valiloxybate, a Novel Once-at-Bedtime Oxybate for Sleep Disorders - Quiver Quantitative
Avadel Pharmaceuticals Strengthens Sleep Medicine Portfolio with Exclusive License of Valiloxybate from XWPharma Ltd - The Manila Times
Salt-Free Sleep Drug Deal: Avadel Pharma Expands Portfolio with $20M Valiloxybate License for Narcolepsy - Stock Titan
Is Avadel Pharmaceuticals plc currently under institutional pressureJuly 2025 Recap & Reliable Breakout Stock Forecasts - khodrobank.com
Wells Fargo Initiates Avadel Pharmaceuticals at Equalweight With $16 Price Target - MarketScreener
Applying Elliott Wave Theory to Avadel Pharmaceuticals plc2025 Fundamental Recap & Weekly High Return Forecasts - Newser
Is now a turning point for Avadel Pharmaceuticals plcMarket Activity Summary & Breakout Confirmation Trade Signals - Newser
Is Avadel Pharmaceuticals plc a candidate for recovery playEarnings Risk Summary & Smart Swing Trading Alerts - Newser
Is a relief rally coming for Avadel Pharmaceuticals plc holdersQuarterly Risk Review & Expert Curated Trade Setup Alerts - Newser
Will Avadel Pharmaceuticals plc benefit from macro trendsForecast Cut & Advanced Technical Analysis Signals - Newser
Avadel Pharmaceuticals plc stock chart pattern explained2025 Market Outlook & AI Forecast Swing Trade Picks - Newser
Tick level data insight on Avadel Pharmaceuticals plc volatilityJuly 2025 Big Picture & Real-Time Chart Breakout Alerts - Newser
Can you recover from losses in Avadel Pharmaceuticals plcInflation Watch & Free Risk Controlled Daily Trade Plans - Newser
Sector ETF performance correlation with Avadel Pharmaceuticals plcWeekly Volume Report & Weekly High Conviction Ideas - Newser
Will Avadel Pharmaceuticals plc continue its uptrendQuarterly Risk Review & Daily Risk Controlled Trade Plans - Newser
Custom watchlist performance reports with Avadel Pharmaceuticals plcJuly 2025 Short Interest & Proven Capital Preservation Methods - Newser
Will Avadel Pharmaceuticals plc outperform the marketPortfolio Gains Summary & Accurate Trade Setup Notifications - Newser
Smart tools for monitoring Avadel Pharmaceuticals plc’s price action2025 Support & Resistance & Long-Term Growth Stock Strategies - Newser
What earnings revisions data tells us about Avadel Pharmaceuticals plcJuly 2025 Momentum & Fast Gain Swing Alerts - Newser
Predicting Avadel Pharmaceuticals plc trend using moving averagesInsider Selling & Technical Entry and Exit Tips - Newser
Published on: 2025-09-02 22:45:08 - Newser
Is now the right time to enter Avadel Pharmaceuticals plcMarket Volume Summary & Real-Time Market Sentiment Alerts - khodrobank.com
Pullback Watch: Is Avadel Pharmaceuticals plc exposed to political riskMarket Activity Summary & High Return Trade Guides - khodrobank.com
Can Avadel Pharmaceuticals plc benefit from deglobalizationQuarterly Performance Summary & Community Driven Trade Alerts - khodrobank.com
Avadel Pharmaceuticals plc (AVDL)’s LUMRYZ™ Sales Surge 64% in Breakout Quarter - MSN
How to use a screener to detect Avadel Pharmaceuticals plc breakoutsWeekly Trade Review & Accurate Intraday Trade Tips - Newser
Is Avadel Pharmaceuticals plc building a consolidation base2025 Fundamental Recap & Consistent Profit Alerts - Newser
How to read the order book for Avadel Pharmaceuticals plcBond Market & Daily Technical Forecast Reports - Newser
Risk adjusted return profile for Avadel Pharmaceuticals plc analyzedJuly 2025 Selloffs & Real-Time Volume Analysis - Newser
Trend analysis for Avadel Pharmaceuticals plc this weekPortfolio Risk Report & Free Fast Gain Swing Trade Alerts - Newser
Avadel Pharmaceuticals plc Inches Above Key Support — Safe to Hold getLinesFromResByArray error: size == 0 - kangso.co.kr
Avadel Pharmaceuticals plc stock momentum explainedWeekly Gains Report & AI Powered Market Trend Analysis - Newser
Finanzdaten der Avadel Pharmaceuticals Plc-Aktie (AVDL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Avadel Pharmaceuticals Plc-Aktie (AVDL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Thornton Peter J. | Director |
Jan 13 '25 |
Buy |
8.04 |
10,000 |
80,450 |
104,055 |
| Ende Eric J | Director |
Jan 13 '25 |
Buy |
7.84 |
30,000 |
235,218 |
208,900 |
| MCHUGH THOMAS S | Chief Financial Officer |
Dec 13 '24 |
Buy |
10.44 |
2,300 |
24,019 |
87,800 |
| MCHUGH THOMAS S | Chief Financial Officer |
Dec 11 '24 |
Buy |
10.49 |
5,000 |
52,432 |
85,500 |
| Divis Gregory J | Chief Executive Officer |
Dec 06 '24 |
Buy |
9.98 |
9,598 |
95,759 |
9,598 |
| Divis Gregory J | Chief Executive Officer |
Dec 09 '24 |
Buy |
9.82 |
402 |
3,948 |
10,000 |
| Glass Geoffrey Michael | Director |
Dec 10 '24 |
Buy |
9.84 |
20,279 |
199,641 |
75,904 |
| Palczuk Linda | Director |
Dec 06 '24 |
Buy |
10.19 |
3,000 |
30,568 |
66,400 |
3.60%
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):